Science Minister Opens Gradipore Global Headquarters

Senator Nick Minchin officially opened Australian biotechnology company Gradipore's global headquarters and laboratory complex.

Senator Minchin said Gradipore represented a text book example of what the government was aiming to achieve through its National Biotechnology Strategy. The government believes science and innovation will underpin future sustainable growth in our economy, with biotechnology playing a key role.

Gradipore is a company which researches, develops, manufactures and markets biological separation technologies for the life science market. The company's biological separations technology has broad applicability to all areas of science. These include blood fractionation, biological separations, drugs, dialysis, viral removal and industry.

The company's separations technology platform, known as Gradiflow, represents a paradigm shift in terms of improved yield, quality of product and time taken when compared with existing technologies.

The building in Sydney's French's Forest, comprises 4400 square metres of office accommodation and state-of-the-art laboratories for research work and manufacturing. It is designed to accommodate Gradipore's Australian team of more than 80 administrative, sales, marketing and research personnel.